Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

This randomised, double-blind, placebo-controlled study was designed to evaluate the ability of the orally administered matrix metalloproteinase inhibitor, marimastat, to prolong survival in patients with non-resectable gastric and gastro-oesophageal adenocarcinoma. Three hundred and sixty-nine pati...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bramhall, S R, Hallissey, M T, Whiting, J, Scholefield, J, Tierney, G, Stuart, R C, Hawkins, R E, McCulloch, P, Maughan, T, Brown, P D, Baillet, M, Fielding, J W L
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2002
Предметы:
Clinical
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375430/
https://ncbi.nlm.nih.gov/pubmed/12085177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600310
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы